Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2012
04/10/2012US8153149 Controlled delivery system
04/10/2012US8153147 Heparin coating of biological tissue
04/10/2012US8153144 Stable multiphase composition comprising alkylamphoacetate
04/10/2012US8153141 Immunostimulatory G, U-containing oligoribonucleotides
04/10/2012US8153138 Recombinant MVA virus
04/10/2012US8153112 Compositions and methods for treating cavity conditions
04/10/2012US8153111 Photo-triggered release of active substances from dendrimer-photosensitizer complexes
04/10/2012US8153104 Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
04/10/2012CA2687078C Novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives
04/10/2012CA2676003C Compositions of stable tiacumicins
04/10/2012CA2669680C Compounds for inhibiting mitotic progression
04/10/2012CA2662967C Medicinal composition
04/10/2012CA2660167C Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
04/10/2012CA2634646C Pyrimidine derivatives for the treatment of abnormal cell growth
04/10/2012CA2632567C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
04/10/2012CA2626099C Oral composition containing morin
04/10/2012CA2607098C Dispersible bosentan tablet
04/10/2012CA2598893C Eml4-alk fusion gene
04/10/2012CA2573977C Nicotinic receptor agonists for the treatment of inflammatory diseases
04/10/2012CA2571984C Antiviral compounds
04/10/2012CA2549147C Tricyclic 1-((3-indol-3-yl)carbonyl) piperazine derivatives as cannabinoid cb1 receptor agonists
04/10/2012CA2548897C Endoparasiticidal agents for topical application
04/10/2012CA2544417C Ectoparasiticidal formulations of spinosyns and azole pesticides
04/10/2012CA2540052C Methylphenidate solution and associated methods of administration and production
04/10/2012CA2531732C Prodrugs of 9-aminomethyl tetracycline compounds
04/10/2012CA2529575C Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
04/10/2012CA2528483C Compositions and methods for increasing telomerase activity
04/10/2012CA2526540C Cyclicamino-phenyl sulfamate derivatives
04/10/2012CA2519980C Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
04/10/2012CA2514384C 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
04/10/2012CA2514124C Absorption enhancing agents
04/10/2012CA2506960C Derivatives of pyridinalkyl-aminoalkyl-1h-indole inhibiting receptors 5-ht and recapture of serotonin which can be used as antidepressant and anxiolytic
04/10/2012CA2504935C Induction of the mitochondrial permeability transition
04/10/2012CA2499822C Novel pyrimidineamide derivatives and the use thereof
04/10/2012CA2498191C Method of inhibiting choroidal neovascularization
04/10/2012CA2497725C Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
04/10/2012CA2491802C Novel compounds, pharmaceutical compositions containing same, and methods of use for same
04/10/2012CA2486663C Method of treating rosacea by topical application of a cyclohexane derivative
04/10/2012CA2486308C Hepatitis c virus inhibitors
04/10/2012CA2484375C Oral dosage forms comprising fenofibrate
04/10/2012CA2477241C Compositions and methods for treating epithelial and retinal tissue diseases
04/10/2012CA2474520C Solid alginate compositions for use in treating gastric disorders
04/10/2012CA2468496C Ilk inhibitors for the treatment of renal disease
04/10/2012CA2455155C Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
04/10/2012CA2446506C Methods for treating delirium using glucocorticoid receptor-specific antagonists
04/10/2012CA2445408C Quinolone carboxylic acid compositions and related methods of treatment
04/10/2012CA2385325C Chlamydia antigens and corresponding dna fragments and uses thereof
04/10/2012CA2378456C Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
04/10/2012CA2238843C Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
04/05/2012WO2012045090A2 Therapeutic use of a tlr agonist and combination therapy
04/05/2012WO2012045089A2 Methods for the treatment of allergic diseases
04/05/2012WO2012045083A2 Minimizing intestinal dysfunction
04/05/2012WO2012045072A2 Sugar-based dispersion
04/05/2012WO2012045020A1 Combinations of 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide and fludarabine
04/05/2012WO2012045018A1 Aryl-substituted imidazoles
04/05/2012WO2012045010A1 Combinations of 4-(3-(2h-1,2,3-triazo-2-yl) phenylamino)-2-((1r,2s)-2-aminocyclohexylamino) pyrimidine-5-carboxamide and fludarabine
04/05/2012WO2012045009A2 Polyphosphate and pyrophosphate derivative of saccharides
04/05/2012WO2012045007A1 Method of preparation of (4 - {4 -acetylamino- 2 - [3- ( 2 - isopropyl - thiazol - 4 - ylmethyl) - 3 -methyl - ureido] - butyryl amino} -1 -benzyl- 5 -phenyl- pentyl) -carbamic acid thiazol - 5 - ylmethyl ester
04/05/2012WO2012044993A1 Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
04/05/2012WO2012044963A2 Perfluorocarbons for use in treating pruritus
04/05/2012WO2012044936A1 Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide
04/05/2012WO2012044832A1 Methods of treating a subject and related particles, polymers and compositions
04/05/2012WO2012044830A1 Treatment of symptoms associated with menopause
04/05/2012WO2012044825A1 Crystalline oxalate salts of a diamide compound
04/05/2012WO2012044817A2 Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof
04/05/2012WO2012044736A1 Monovalent metal cation dry powders for inhalation
04/05/2012WO2012044613A1 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
04/05/2012WO2012044595A1 Dabigatran etexilate bismesylate salt, solid state forms and process for preparation thereof
04/05/2012WO2012044577A1 Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
04/05/2012WO2012044574A1 Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
04/05/2012WO2012044572A1 Dual inhibitors of met and vegf for the treatment of castration- resistant prostate cancer and osteoblastic bone metastases
04/05/2012WO2012044567A2 Imidazole derivatives
04/05/2012WO2012044562A2 Pyrazolopyrimidine pde10 inhibitors
04/05/2012WO2012044561A2 2-alkoxy pyrimidine pde10 inhibitors
04/05/2012WO2012044537A1 Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators
04/05/2012WO2012044531A1 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
04/05/2012WO2012044265A1 Use of mirnas for the diagnosis, prophylaxis, treatment and follow-up of diseases involving macroautophagy abnormalities
04/05/2012WO2012044243A1 Crystalline naloxol-peg conjugate
04/05/2012WO2012044242A1 Use of a food product comprising viscous fibres which has a beneficial effect on cognitive performance.
04/05/2012WO2012044189A1 A new hydrated crystalline form of perindopril erbumine, methods for its preparation and its use in pharmaceutical preparations
04/05/2012WO2012044162A1 Fat composition for programming immune response
04/05/2012WO2012044155A1 Fat composition for programming immune response
04/05/2012WO2012044140A1 Anti-tuberculosis preparation in tablet form and process for preparing same
04/05/2012WO2012044139A2 Novel use of cryptotanshinone
04/05/2012WO2012044090A2 Novel aminoquinazoline compound having a protein-kinase inhibiting action
04/05/2012WO2012044046A2 Novel methylcyclohexane derivatives and uses thereof
04/05/2012WO2012043949A1 Composition for enhancing immunity containing compounds represented by chemical formulas 1-8 or sophora flavescens extract as active ingredient
04/05/2012WO2012043900A1 Pharmaceutical composition containing quinoline derivative
04/05/2012WO2012043891A1 Agent for treatment of eye diseases
04/05/2012WO2012043808A1 Heat shock protein expression inducer
04/05/2012WO2012043801A1 Patch
04/05/2012WO2012043791A1 1,2,4-triazolone derivative
04/05/2012WO2012043780A1 Orally ingestible skin activator and process for production thereof
04/05/2012WO2012043747A1 Glioma treatment method, glioma examination method, method of delivering a desired material to a glioma, and drug used in said methods
04/05/2012WO2012043709A1 Preparation for improving solubility of poorly soluble drug
04/05/2012WO2012043701A1 Transdermal absorption preparation
04/05/2012WO2012043700A1 Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
04/05/2012WO2012043696A1 Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide
04/05/2012WO2012043680A1 水系皮膚外用剤aqueous topical preparation for use on skin
04/05/2012WO2012043638A1 (aza)indolizine derivative and pharmaceutical use thereof
1 ... 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 ... 7860